Company BCAL Diagnostics Limited
Equities
BDX
AU0000160921
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.095 AUD | +2.15% | 0.00% | -4.04% |
03-06 | BCAL Diagnostics Appoints CEO | MT |
02-20 | BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shane Ryan
CEO | Chief Executive Officer | - | 23-09-20 |
Guy Robertson
DFI | Director of Finance/CFO | 70 | - |
Chief Tech/Sci/R&D Officer | - | 22-03-31 | |
Amani Batarseh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Director/Board Member | 75 | 22-02-13 | |
Rebecca Shaw
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Jayne Shaw
FOU | Founder | - | 09-12-31 |
Director/Board Member | 75 | 22-02-13 | |
Jonathan Trollip
BRD | Director/Board Member | - | 20-12-22 |
Founder | - | 09-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 251,639,158 | 115,377,616 ( 45.85 %) | 0 | 45.85 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.04% | 15.52M | |
-1.19% | 12.56B | |
-6.06% | 7.68B | |
-0.28% | 5.29B | |
+21.05% | 5.24B | |
+2.05% | 4.57B | |
-51.13% | 3.29B | |
+7.80% | 2.6B | |
-8.63% | 2.2B | |
-0.96% | 1.79B |
- Stock Market
- Equities
- BDX Stock
- Company BCAL Diagnostics Limited